Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder.

OBJECTIVE Psychostimulants are partially effective in reducing cognitive dysfunction associated with attention-deficit/hyperactivity disorder (ADHD). Cognitive effects of guanfacine, an alternative treatment, are poorly understood. Given its distinct action on α2A receptors, guanfacine may have different or complementary effects relative to stimulants. This study tested stimulant and guanfacine monotherapies relative to combined treatment on cognitive functions important in ADHD. METHOD Children with ADHD (n = 182; aged 7-14 years) completed an 8-week, double blind, randomized, controlled trial with 3 arms: d-methylphenidate (DMPH), guanfacine (GUAN), or combination treatment with DMPH and GUAN (COMB). A nonclinical comparison group (n = 93) had baseline testing, and a subset was retested 8 weeks later (n = 38). Analyses examined treatment effects in 4 cognitive domains (working memory, response inhibition, reaction time, and reaction time variability) constructed from 20 variables. RESULTS The ADHD group showed impaired working memory relative to the nonclinical comparison group (effect size = -0.53 SD unit). The treatments differed in effects on working memory but not other cognitive domains. Combination treatment improved working memory more than GUAN but was not significantly better than DMPH alone. Treatment did not fully normalize the initial deficit in ADHD relative to the comparison group. CONCLUSION Combined treatment with DMPH and GUAN yielded greater improvements in working memory than placebo or GUAN alone, but the combined treatment was not superior to DMPH alone and did not extend to other cognitive domains. Although GUAN may be a useful add-on treatment to psychostimulants, additional strategies appear to be necessary to achieve normalization of cognitive function in ADHD. CLINICAL TRIAL REGISTRATION INFORMATION Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder; http://clinicaltrials.gov/; NCT00429273.

[1]  Philip D. Harvey,et al.  The Effects of Guanfacine on Context Processing Abnormalities in Schizotypal Personality Disorder , 2007, Biological Psychiatry.

[2]  T. Wilens,et al.  A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. , 2012, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  A. Arnsten,et al.  Adrenergic pharmacology and cognition: focus on the prefrontal cortex. , 2007, Pharmacology & therapeutics.

[4]  J. Biederman,et al.  Long-Term, Open-Label Extension Study of Guanfacine Extended Release in Children and Adolescents with ADHD , 2008, CNS Spectrums.

[5]  K. Lange,et al.  Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder , 2006, Psychopharmacology.

[6]  R. Barkley.  Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. , 2002, The Journal of clinical psychiatry.

[7]  J. Halperin,et al.  Neural mechanisms underlying the therapeutic actions of guanfacine treatment in youth with ADHD: A pilot fMRI study , 2015, Psychiatry Research: Neuroimaging.

[8]  R. Tannock,et al.  Working Memory Impairments in Children with Attention-Deficit Hyperactivity Disorder With and Without Comorbid Language Learning Disorders , 2006, Journal of clinical and experimental neuropsychology.

[9]  T. Roth,et al.  Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder. , 2011, Journal of child and adolescent psychopharmacology.

[10]  Alexandra Sturm,et al.  Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[11]  P. Goldman-Rakic,et al.  The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  S. Hogg-Johnson,et al.  A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[13]  M. Brammer,et al.  Effects of Stimulants on Brain Function in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis , 2014, Biological Psychiatry.

[14]  A. Arnsten,et al.  Guanfacine for the Treatment of Cognitive Disorders: A Century of Discoveries at Yale , 2012, The Yale journal of biology and medicine.

[15]  P. Jäkälä,et al.  Clonidine, but not Guanfacine, Impairs Choice Reaction Time Performance in Young Healthy Volunteers , 1999, Neuropsychopharmacology.

[16]  J. Halperin,et al.  Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control , 2012, Psychopharmacology.

[17]  A. Arnsten,et al.  Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology , 2009, CNS Drugs.

[18]  J. Currie,et al.  Effects of Methylphenidate on Cognitive Functions in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Evidence from a Systematic Review and a Meta-Analysis , 2014, Biological Psychiatry.

[19]  R. Barkley.  Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. , 1997, Psychological bulletin.

[20]  Deepti R. Bathula,et al.  Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD , 2012, Proceedings of the National Academy of Sciences.

[21]  C. Sugar,et al.  Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[22]  C. Advokat.  What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD) , 2010, Neuroscience & Biobehavioral Reviews.

[23]  R. Kessler,et al.  Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. , 2007, The British journal of psychiatry : the journal of mental science.

[24]  M. Arns,et al.  EEG-vigilance and response to stimulants in paediatric patients with attention deficit/hyperactivity disorder , 2010, Clinical Neurophysiology.

[25]  N. Ryan,et al.  K-SADS-PL. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[26]  J. Newcorn,et al.  Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[27]  K. Matthews,et al.  Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder , 2004, Psychopharmacology.

[28]  Colin Studholme,et al.  The Alpha-2A-Adrenoceptor Agonist, Guanfacine, Increases Regional Cerebral Blood Flow in Dorsolateral Prefrontal Cortex of Monkeys Performing a Spatial Working Memory Task , 2000, Neuropsychopharmacology.

[29]  A. Arnsten,et al.  Catecholamine mechanisms in the prefrontal cortex: proven strategies for enhancing higher cognitive function , 2015, Current Opinion in Behavioral Sciences.

[30]  Eliza Congdon,et al.  Neural activation during response inhibition in adult attention-deficit/hyperactivity disorder: Preliminary findings on the effects of medication and symptom severity , 2014, Psychiatry Research: Neuroimaging.

[31]  J. McGough,et al.  Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[32]  B. Pennington,et al.  Validity of the Executive Function Theory of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review , 2005, Biological Psychiatry.